Announcement Date: May 16, 2026 Spokesperson Date: May 15, 2026 Spokesperson Time: 21:16:40 Company Code: 6550 Company Name: Polaris Pharmaceuticals-KY Subject: Announcement of the Board of Directors' resolution to appoint members of the Remuneration Committee Clause Compliance: Clause 6 Date of Fact Occurrence: May 15, 2026 Description: 1. Date of Change: 115/05/15 (May 15, 2026) 2. Functional Committee Name: Remuneration Committee 3. Former Members: Independent Director: Wei Zongde Independent Director: Zhao Yingcheng Independent Director: Wen (Ri Min) Guolan 4. Former Members' Brief: Independent Director: Wei Zongde Independent Director: Zhao Yingcheng Independent Director: Wen (Ri Min) Guolan 5. New Members: Independent Director: Zhao Yingcheng Independent Director: Di Shijie Independent Director: Zhang Zhigang 6. New Members' Brief: Independent Director: Zhao Yingcheng / Independent Director of this company Independent Director: Di Shijie / Associate Professor at the University of Hong Kong Independent Director: Zhang Zhigang / CEO of Zhongen Biomedical 7. Change Details (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Death', or 'New Appointment'): Term Expiration 8. Reason for Change: Comprehensive re-election of directors (including independent directors) at the 2026 Annual General Meeting. 9. Original Term (e.g., xx/xx/xx ~ xx/xx/xx): 112/09/26 ~ 115/06/11 (September 26, 2023 ~ June 11, 2026) 10. New Effective Date: 115/05/15 (May 15, 2026) 11. Other Matters to be Notified: None
FACT BOX
- Source: PR Times
- Category: Corporate Governance